CAMP4 THERAPEUTICS CORP (CAMP)
US1281262089
ChartMill assigns a Buy % Consensus number of 86% to CAMP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 19.72. This target is 294.4% above the current price.
CAMP was analyzed by 10 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CAMP.
In the last month the buy percentage rose by 37 points. So the trust of analysts is improving.
CAMP was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-05 | Leerink Partners | Initiate | Outperform |
| 2024-11-05 | William Blair | Initiate | Outperform |
| 2024-11-05 | JP Morgan | Initiate | Overweight |
| 2024-11-05 | Piper Sandler | Initiate | Overweight |
| 2024-01-11 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-10-09 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-10-06 | Roth MKM | Maintains | Buy -> Buy |
| 2023-10-06 | Craig-Hallum | Downgrade | Buy -> Hold |
| 2023-08-29 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-07-13 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-07-11 | Craig-Hallum | Maintains | Buy -> Buy |
| 2023-06-26 | Jefferies | Downgrade | Buy -> Hold |
| 2023-05-01 | Goldman Sachs | Maintains | Sell |
| 2023-04-28 | Craig-Hallum | Maintains | Buy |
| 2023-04-18 | Goldman Sachs | Maintains | Sell |
| 2022-10-14 | Goldman Sachs | Maintains | Sell |
| 2022-08-16 | Craig-Hallum | Upgrade | Hold -> Buy |
| 2021-12-22 | Canaccord Genuity | Maintains | Buy |
| 2021-12-22 | Craig-Hallum | Downgrade | Buy -> Hold |
| 2021-06-25 | Roth Capital | Maintains | Buy |
| 2021-04-23 | Canaccord Genuity | Maintains | Buy |
| 2021-03-18 | Canaccord Genuity | Maintains | Buy |